Note: Recent publications are currently being compiled.

Bone Biology Publications - 2006 to 2007

Refereed Journal Articles

1:  Borba VZ, Paz-Filho G, Kulak CA, Seibel MJ, Bilezikian JP.  Bone turnover 18 months after a single intravenous dose of zoledronic acid.  Int J Clin Pract. 2007 Jun;61(6):1058-62.

2:  Lee P, Jones G, Seibel MJ.  Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?  Eur J Gastroenterol Hepatol. 2007 Apr;19(4):337-40.

3:  Nguyen TV, Meier C, Center JR, Eisman JA, Seibel MJ. Bone turnover in elderly men: relationships to change in bone mineral density.BMC Musculoskelet Disord. 2007 Feb 22;8:13.

4:  Seibel MJ. Biochemical Markers of Bone Turnover Part II: Clinical Applications in the Management of Osteoporosis.  Clin Biochem Rev. 2006 Aug;27(3):123-38.

5:  Sambrook PN, Cameron ID, Chen JS, Cumming RG, Lord SR, March LM, Schwarz J,
Seibel MJ, Simpson JM. Influence of fall related factors and bone strength on fracture risk in the frail elderly.  Osteoporosis Int. 2007 May;18(5):603-10.

6:  Dunstan CR, Felsenberg D, Seibel MJ. Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol. 2007 Jan;4(1):42-55. Review.

7:  Seibel MJ, Dunstan CR, Zhou H, Allan CM, Handelsman DJ.  Sex steroids, not FSH, influence bone mass.Cell. 2006 Dec 15;127(6):1079;

8:  Seibel MJ.  Clinical application of biochemical markers of bone turnover.  Arq Bras Endocrinol Metabol. 2006 Aug;50(4):603-20.

9:  Zheng Y, Zhou H, Brennan K, Blair JM, Modzelewski JR, Seibel MJ, Dunstan CR.
 Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. Bone. 2007 Feb;40(2):471-8.

10:  Malkin I, Bigman G, Matias R, Kalichman L, Seibel MJ, Kobyliansky E, Livshits G.
Age-related changes of bone strength phenotypes: observational follow-up study of hand bone mineral density.Osteoporos Int. 2006 Oct 12; [Epub ahead of print]

11:  Nelson AE, Howe CJ, Nguyen TV, Leung KC, Trout GJ, Seibel MJ, Baxter RC,
Handelsman DJ, Kazlauskas R, Ho KK. Influence of demographic factors and sport type on growth hormone-responsivemarkers in elite athletes. J Clin Endocrinol Metab. 2006 Nov;91(11):4424-32.

12:  Chen JS, Seibel MJ, Zochling J, March L, Cameron ID, Cumming RG, Schwarz J,
Simpson JM, Sambrook PN.  Calcaneal ultrasound but not bone turnover predicts fractures in vitamin D deficient frail elderly at high risk of falls. Calcif Tissue Int. 2006 Jul;79(1):37-42.

13:  Sambrook PN, Chen CJ, March L, Cameron ID, Cumming RG, Lord SR, Simpson JM, Seibel MJ. High bone turnover is an independent predictor of mortality in the frail elderly.J Bone Miner Res. 2006 Apr;21(4):549-55.

14:  Meier C, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, Seibel MJ.  Serum cathepsin K concentrations reflect osteoclastic activity in women with
postmenopausal osteoporosis and patients with Paget's disease.  Clin Lab. 2006;52(1-2):1-10.

15:  Chen JS, Cameron ID, Cumming RG, Lord SR, March LM, Sambrook PN, Simpson
JM, Seibel MJ.  Effect of age-related chronic immobility on markers of bone turnover.
J Bone Miner Res. 2006 Feb;21(2):324-31.

16:  Blair JM, Zhou H, Seibel MJ, Dunstan CR.  Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol. 2006 Jan;3(1):41-9. Review.

17:  Sims NA, Brennan K, Spaliviero J, Handelsman DJ, Seibel MJ.  Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E456-62.

 18:  Padagas J, Colloton M, Shalhoub V, Kostenuik P, Morony S, Munyakazi L, Guo M, Gianneschi D, Shatzen E, Geng Z, Tan HL, Dunstan C, Lacey D, Martin D. The receptor activator of nuclear factor-kappa B ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism Calcif Tissue Int 2006; 78 (1): 35-44.

19:  Geusens PP, Landewé RBM, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DMFM, van der Linden S, Boers M. The ratio of circulating osteoprotegerin (OPG) and receptor activator of nuclear factor κB-ligand (RANKL) in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 2006; 54:1772-1777.

20:  Zheng Y, Zhou H, Modzelewski JRK, Kalak R, Blair JM, Seibel MJ, Dunstan CR.  Accelerated Bone Resorption, Due to Dietary Calcium Deficiency, Promotes Breast Cancer Tumor Growth in Bone.  Cancer Res (in press) 2007